Why should we be doing research in the first place?
Research is essential to find out what treatments work best for patients, and to ultimately improve service delivery and care. Without it we wouldn’t know if we were providing the best care that we could for patients. Research also helps us to understand conditions better.
What does the Research and Innovation department do?
The R&I department is here to assist and support the Trust in running high quality applied research. The department is here to also develop research capacity of the Trust, so we can take on more commercial studies, as well as support and develop Trust staff in regards to research skills.
Our vision is to embed research into everyday clinical work and to give every patient the opportunity to take part in research.
Supporting Research at BCPFT
BCPFT is committed to supporting and adopting clinical research trials across the Trust. Please see the current clinical trials that have been active in 2017/18.
|REC Number:||16/LO/1820||IRAS Number:||212826|
|Name of Clinical Trial:||Effects of intranasal naloxone on eating behaviours in Bulimia Nervosa.|
|Date Site Invited:||25/02/2017||Date Site Selected:||25/02/2017|
|Date HRA Permission Granted:||07/02/2017||Date Site Confirmed by Sponsor:||12/04/2017|
|Date Site Confirmed:||12/04/2017||Date site is ready to start:||12/04/2017|
|Date of recruitment of first patient:||26/04/2017|
|Benchmark achieved?||Yes||Reason for not doing so:||N/A|
|REC Number:||16/NW/0888||IRAS Number:||213646|
|Name of Clinical Trial:||everyBody Plus - Using internet-based self-help to bridge waiting time for face-to-face outpatient treatment for bulimia nervosa, binge eating disorder and Other Specified Feeding and Eating Disorders (OSFED)|
|Date Site Invited:||27/11/2017||Date Site Selected:||11/12/2017|
|Date HRA Permission Granted:||02/02/2017||Date Site Confirmed by Sponsor:||12/02/2018|
|Date Site Confirmed:||12/02/2018||Date site is ready to start:||12/02/2018|
|Date of recruitment of first patient:||05/04/2018|
|Benchmark achieved?||No||Reason for not doing so:||Sponsor Delay|
|REC Number:||16/NW/0566||IRAS Number:||209226|
|Name of Trial:||Prospective non-interventional study of patients with mild to moderate Alzheimer's Disease and their caregivers in four European countries.|
|Whether a target number of patients was agreed:||Number agreed||Minimum number of patients agreed to be recruited:||15|
|Maximum number of patients agreed to be recruited:||15||Whether a target date to recruite patients was agreed:||Date agreed|
|Date agreed to recruit target number of patients:||31/12/2017|
|Total number of patients recruited at target date:||15||Total number of study participants recuited:||15|
|Date trial closed to recuitment:||31/12/2017||Reason for closure of trial:||Recruitment finished|